Endocrinology, Vol 132, 224-234, Copyright © 1993 by Endocrine Society

ARTICLES

Neuropeptide Y administered chronically into the lateral ventricle profoundly inhibits both the gonadotropic and the somatotropic axis in intact adult female rats

C Catzeflis, DD Pierroz, F Rohner-Jeanrenaud, JE Rivier, PC Sizonenko and ML Aubert
Department of Pediatrics, University of Geneva School of Medicine, Switzerland.

Neuropeptide Y (NPY) is known to be involved in the central regulation of appetite, sexual behavior, and reproductive functions. Whereas central administration of NPY strongly stimulates feeding in satiated animals, diet restriction produces overexpression of NPY in the arcuate and paraventricular nuclei that might reflect behavioral adaptations to shortage of food. Previous studies indicated that central administration of NPY resulted in controversial actions on LH secretion, either stimulatory or inhibitory. In order to analyze the chronic effect on pituitary function of centrally administered NPY, stainless steel cannulae were implanted in the right lateral ventricles of intact 45-day-old Sprague-Dawley female rats. Ten days later, Alzet osmotic minipumps filled with saline or different concentrations of NPY adjusted to deliver 3, 6, 12, or 18 micrograms/day were connected to the intracerebroventricular (icv) cannulae, implanted sc dorsally, and the effects of these treatments evaluated after 7 days. Chronic icv infusion of NPY produced the expected dose-related increase in food intake [25.3 +/- 0.8 g/day (basal) to 47.9 +/- 4.3 g/day (highest NPY dose)] and body wt gain (3.7 +/- 0.4-11.5 +/- 1.4 g/day). Basal insulinemia was highly correlated to the increase in food intake. This orexigenic action of NPY was accompanied by a drastic dose-related decrease in pituitary wt (14.0 +/- 0.5-8.3 +/- 0.3 mg), pituitary concentration of GnRH receptors, a known marker of the activity of the hypothalamo-pituitary gonadal axis (15.2 +/- 1.7-5.2 +/- 0.5 fmol/mg), and ovarian wt (84.0 +/- 4.2-49 +/- 6.7 mg). Ovulation was impaired in NPY-treated animals as seen by daily inspection of vaginal smears. A sharp dose-dependent decrease in plasma levels of insulin-like growth factor I was also observed [934 +/- 64 ng/ml (basal) to 385 +/- 26 ng/ml (highest NPY dose)], probably secondary to a decrease in GH secretion. Whereas these data confirm the central action of NPY to stimulate appetite in satiated animals, they provide the first demonstration that chronic icv administration of NPY unequivocally inhibits gonadotropin secretion and sexual function in intact female rats. These data also confirm that NPY can suppress GH secretion and other anabolic hormones. In conclusion, these results may indicate a physiological role of NPY as an integrator of different adaptive behaviors in periods of unfavorable metabolic conditions such as diet restriction, extending its action to inhibition of sexual functions and anabolic processes.

This article has been cited by other articles:

				W. Huang, M. Acosta-Martinez, and J. E. Levine Ovarian Steroids Stimulate Adenosine Triphosphate-Sensitive Potassium (KATP) Channel Subunit Gene Expression and Confer Responsiveness of the Gonadotropin-Releasing Hormone Pulse Generator to KATP Channel Modulation Endocrinology, May 1, 2008; 149(5): 2423 - 2432. [Abstract] [Full Text] [PDF]

				R. M. Luque, R. D. Kineman, and M. Tena-Sempere Regulation of Hypothalamic Expression of KiSS-1 and GPR54 Genes by Metabolic Factors: Analyses Using Mouse Models and a Cell Line Endocrinology, October 1, 2007; 148(10): 4601 - 4611. [Abstract] [Full Text] [PDF]

				S. Lin, E.-J. D. Lin, D. Boey, N. J. Lee, K. Slack, M. J. During, A. Sainsbury, and H. Herzog Fasting Inhibits the Growth and Reproductive Axes via Distinct Y2 and Y4 Receptor-Mediated Pathways Endocrinology, May 1, 2007; 148(5): 2056 - 2065. [Abstract] [Full Text] [PDF]

				E.-J. D. Lin, A. Sainsbury, N. J. Lee, D. Boey, M. Couzens, R. Enriquez, K. Slack, R. Bland, M. J. During, and H. Herzog Combined Deletion of Y1, Y2, and Y4 Receptors Prevents Hypothalamic Neuropeptide Y Overexpression-Induced Hyperinsulinemia despite Persistence of Hyperphagia and Obesity Endocrinology, November 1, 2006; 147(11): 5094 - 5101. [Abstract] [Full Text] [PDF]

				T. Komatsu, T. Chiba, H. Yamaza, K. To, H. Toyama, Y. Higami, and I. Shimokawa Effect of leptin on hypothalamic gene expression in calorie-restricted rats. J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2006; 61(9): 890 - 898. [Abstract] [Full Text] [PDF]

				L. Pinilla, R. Fernandez-Fernandez, E. Vigo, V. M. Navarro, J. Roa, J. M. Castellano, R. Pineda, M. Tena-Sempere, and E. Aguilar Stimulatory effect of PYY-(3-36) on gonadotropin secretion is potentiated in fasted rats Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1162 - E1171. [Abstract] [Full Text] [PDF]

				J. Iqbal, T. R. Manley, P. Ciofi, and I. J. Clarke Reduction in Adiposity Affects the Extent of Afferent Projections to Growth Hormone-Releasing Hormone and Somatostatin Neurons and the Degree of Colocalization of Neuropeptides in Growth Hormone-Releasing Hormone and Somatostatin Cells of the Ovine Hypothalamus Endocrinology, November 1, 2005; 146(11): 4776 - 4785. [Abstract] [Full Text] [PDF]

				I. J. Clarke, K. Backholer, and A. J. Tilbrook Y2 Receptor-Selective Agonist Delays the Estrogen-Induced Luteinizing Hormone Surge in Ovariectomized Ewes, but Y1-Receptor-Selective Agonist Stimulates Voluntary Food Intake Endocrinology, February 1, 2005; 146(2): 769 - 775. [Abstract] [Full Text] [PDF]

				G. N. Wade and J. E. Jones Neuroendocrinology of nutritional infertility Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2004; 287(6): R1277 - R1296. [Abstract] [Full Text] [PDF]

				J. W. Hill, J. H. Urban, M. Xu, and J. E. Levine Estrogen Induces Neuropeptide Y (NPY) Y1 Receptor Gene Expression and Responsiveness to NPY in Gonadotrope-Enriched Pituitary Cell Cultures Endocrinology, May 1, 2004; 145(5): 2283 - 2290. [Abstract] [Full Text] [PDF]

				S. D. Sullivan and S. M. Moenter {gamma}-Aminobutyric Acid Neurons Integrate and Rapidly Transmit Permissive and Inhibitory Metabolic Cues to Gonadotropin-Releasing Hormone Neurons Endocrinology, March 1, 2004; 145(3): 1194 - 1202. [Abstract] [Full Text] [PDF]

				P. D. Raposinho, T. Pedrazzini, R. B. White, R. D. Palmiter, and M. L. Aubert Chronic Neuropeptide Y Infusion into the Lateral Ventricle Induces Sustained Feeding and Obesity in Mice Lacking Either Npy1r or Npy5r Expression Endocrinology, January 1, 2004; 145(1): 304 - 310. [Abstract] [Full Text] [PDF]

				G. F. Turi, Z. Liposits, S. M. Moenter, C. Fekete, and E. Hrabovszky Origin of Neuropeptide Y-Containing Afferents to Gonadotropin-Releasing Hormone Neurons in Male Mice Endocrinology, November 1, 2003; 144(11): 4967 - 4974. [Abstract] [Full Text] [PDF]

				F. Elefteriou, S. Takeda, X. Liu, D. Armstrong, and G. Karsenty Monosodium Glutamate-Sensitive Hypothalamic Neurons Contribute to the Control of Bone Mass Endocrinology, September 1, 2003; 144(9): 3842 - 3847. [Abstract] [Full Text] [PDF]

				A. M. Haqq, D. D. Stadler, R. G. Rosenfeld, K. L. Pratt, D. S. Weigle, R. S. Frayo, S. H. LaFranchi, D. E. Cummings, and J. Q. Purnell Circulating Ghrelin Levels Are Suppressed by Meals and Octreotide Therapy in Children with Prader-Willi Syndrome J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3573 - 3576. [Abstract] [Full Text] [PDF]

				A. K. Hewson, L. Y.C. Tung, D. W. Connell, L. Tookman, and S. L. Dickson The Rat Arcuate Nucleus Integrates Peripheral Signals Provided by Leptin, Insulin, and a Ghrelin Mimetic Diabetes, December 1, 2002; 51(12): 3412 - 3419. [Abstract] [Full Text] [PDF]

				F. Zammaretti, G. Panzica, and C. Eva Fasting, Leptin Treatment, and Glucose Administration Differentially Regulate Y1 Receptor Gene Expression in the Hypothalamus of Transgenic Mice Endocrinology, September 1, 2001; 142(9): 3774 - 3782. [Abstract] [Full Text] [PDF]

				C. J. Small, M. S. Kim, S. A. Stanley, J. R.D. Mitchell, K. Murphy, D. G.A. Morgan, M. A. Ghatei, and S. R. Bloom Effects of Chronic Central Nervous System Administration of Agouti-Related Protein in Pair-Fed Animals Diabetes, February 1, 2001; 50(2): 248 - 254. [Abstract] [Full Text]

				P. D. Raposinho, E. Castillo, V. D'alleves, P. Broqua, F. P. Pralong, and M. L. Aubert Chronic Blockade of the Melanocortin 4 Receptor Subtype Leads to Obesity Independently of Neuropeptide Y Action, with No Adverse Effects on the Gonadotropic and Somatotropic Axes Endocrinology, December 1, 2000; 141(12): 4419 - 4427. [Abstract] [Full Text] [PDF]

				C. Li, P. Chen, and M. S. Smith Morphological Evidence for Direct Interaction between Arcuate Nucleus Neuropeptide Y (NPY) Neurons and Gonadotropin-Releasing Hormone Neurons and the Possible Involvement of NPY Y1 Receptors Endocrinology, November 1, 1999; 140(11): 5382 - 5390. [Abstract] [Full Text]

				P. D. Raposinho, P. Broqua, D. D. Pierroz, A. Hayward, Y. Dumont, R. Quirion, J.-L. Junien, and M. L. Aubert Evidence That the Inhibition of Luteinizing Hormone Secretion Exerted by Central Administration of Neuropeptide Y (NPY) in the Rat Is Predominantly Mediated by the NPY-Y5 Receptor Subtype Endocrinology, September 1, 1999; 140(9): 4046 - 4055. [Abstract] [Full Text]

				R. S. Brogan, S. E. Mitchell, P. Trayhurn, and M. S. Smith Suppression of Leptin During Lactation: Contribution of the Suckling Stimulus Versus Milk Production Endocrinology, June 1, 1999; 140(6): 2621 - 2627. [Abstract] [Full Text]

				D. D. Pierroz, A. C. Aebi, I. T. Huhtaniemi, and M. L. Aubert Many LH peaks are needed to physiologically stimulate testosterone secretion: modulation by fasting and NPY Am J Physiol Endocrinol Metab, April 1, 1999; 276(4): E603 - E610. [Abstract] [Full Text] [PDF]

				M. J. Cunningham, D. K. Clifton, and R. A. Steiner Leptin's Actions on the Reproductive Axis: Perspectives and Mechanisms Biol Reprod, February 1, 1999; 60(2): 216 - 222. [Abstract] [Full Text] [PDF]

				A. Giustina and J. D. Veldhuis Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human Endocr. Rev., December 1, 1998; 19(6): 717 - 797. [Abstract] [Full Text]

				C. Li, P. Chen, and M. S. Smith The Acute Suckling Stimulus Induces Expression of Neuropeptide Y (NPY) in Cells in the Dorsomedial Hypothalamus and Increases NPY Expression in the Arcuate Nucleus Endocrinology, April 1, 1998; 139(4): 1645 - 1652. [Abstract] [Full Text] [PDF]

				A. Sahu and S. P. Kalra Absence of Increased Neuropeptide Y Neuronal Activity before and during the Luteinizing Hormone (LH) Surge May Underlie the Attenuated Preovulatory LH Surge in Middle-Aged Rats Endocrinology, February 1, 1998; 139(2): 696 - 702. [Abstract] [Full Text] [PDF]

				C. Karlsson, K. Lindell, E. Svensson, C. Bergh, P. Lind, H. Billig, L. M. S. Carlsson, and B. Carlsson Expression of Functional Leptin Receptors in the Human Ovary J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4144 - 4148. [Abstract] [Full Text] [PDF]

				C. J. Small, D. G. A. Morgan, K. Meeran, M. M. Heath, I. Gunn, C. M. B. Edwards, J. Gardiner, G. M. Taylor, J. D. Hurley, M. Rossi, et al. Peptide analogue studies of the hypothalamic neuropeptide Y receptor mediating pituitary adrenocorticotrophic hormone release PNAS, October 14, 1997; 94(21): 11686 - 11691. [Abstract] [Full Text] [PDF]

				B. S. Singh, T. C. Westfall, and S. U. Devaskar Maternal Diabetes-Induced Hyperglycemia and Acute Intracerebral Hyperinsulinism Suppress Fetal Brain Neuropeptide Y Concentrations Endocrinology, March 1, 1997; 138(3): 963 - 969. [Abstract] [Full Text] [PDF]

				S. L. Dickson and S. M. Luckman Induction of c-fos Messenger Ribonucleic Acid in Neuropeptide Y and Growth Hormone (GH)-Releasing Factor Neurons in the Rat Arcuate Nucleus Following Systemic Injection of the GH Secretagogue, GH-Releasing Peptide-6 Endocrinology, February 1, 1997; 138(2): 771 - 777. [Abstract] [Full Text] [PDF]

				C. L. M. Bivens and D. H. Olster Abnormal Estrous Cyclicity and Behavioral Hyporesponsiveness to Ovarian Hormones in Genetically Obese Zucker Female Rats Endocrinology, January 1, 1997; 138(1): 143 - 148. [Abstract] [Full Text] [PDF]